Telix Pharmaceuticals Limited Increase Decrease Through Other Changes Liabilities Arising From Financing Activities
Telix Pharmaceuticals Limited (TLPPF) reported Increase Decrease Through Other Changes Liabilities Arising From Financing Activities of $126.21 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities · last filed 2026-02-20
AUD
| Period end | Increase Decrease Through Other Changes Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2024-12-31 | -73.56M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 4.10M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Increase Decrease Through Other Changes Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2025-12-31 | $126.21M 20-F · filed 2026-02-20 |
| 2024-12-31 | -$67.22M 20-F · filed 2026-02-20 |